annual operating profit:
$4.09B-$141.50M(-3.34%)Summary
- As of today (June 4, 2025), REGN annual operating income is $4.09 billion, with the most recent change of -$141.50 million (-3.34%) on December 31, 2024.
- During the last 3 years, REGN annual operating profit has fallen by -$4.90 billion (-54.51%).
- REGN annual operating profit is now -54.51% below its all-time high of $8.99 billion, reached on December 31, 2021.
Performance
REGN Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
$591.70M-$398.50M(-40.24%)Summary
- As of today (June 4, 2025), REGN quarterly operating income is $591.70 million, with the most recent change of -$398.50 million (-40.24%) on March 31, 2025.
- Over the past year, REGN quarterly operating profit has dropped by -$159.70 million (-21.25%).
- REGN quarterly operating profit is now -82.32% below its all-time high of $3.35 billion, reached on June 30, 2021.
Performance
REGN quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
$3.83B-$159.70M(-4.00%)Summary
- As of today (June 4, 2025), REGN TTM operating income is $3.83 billion, with the most recent change of -$159.70 million (-4.00%) on March 31, 2025.
- Over the past year, REGN TTM operating profit has dropped by -$20.80 million (-0.54%).
- REGN TTM operating profit is now -57.87% below its all-time high of $9.09 billion, reached on March 31, 2022.
Performance
REGN TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
REGN Operating profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.3% | -21.3% | -0.5% |
| 3 y3 years | -54.5% | -53.0% | -57.9% |
| 5 y5 years | +85.2% | -15.5% | +57.7% |
REGN Operating profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -54.5% | at low | -53.0% | at low | -57.9% | at low |
| 5 y | 5-year | -54.5% | +85.2% | -82.3% | at low | -57.9% | +57.7% |
| alltime | all time | -54.5% | +2094.4% | -82.3% | +1081.0% | -57.9% | +1967.3% |
REGN Operating profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $591.70M(-40.2%) | $3.83B(-4.0%) |
| Dec 2024 | $4.09B(-3.3%) | $990.20M(-16.0%) | $3.99B(+0.4%) |
| Sep 2024 | - | $1.18B(+10.3%) | $3.97B(+1.8%) |
| Jun 2024 | - | $1.07B(+42.3%) | $3.90B(+1.4%) |
| Mar 2024 | - | $751.40M(-22.8%) | $3.85B(-4.8%) |
| Dec 2023 | $4.23B(-15.2%) | $972.90M(-12.4%) | $4.05B(-4.1%) |
| Sep 2023 | - | $1.11B(+9.3%) | $4.22B(-2.6%) |
| Jun 2023 | - | $1.02B(+7.4%) | $4.33B(-2.1%) |
| Mar 2023 | - | $946.70M(-17.4%) | $4.43B(-6.6%) |
| Dec 2022 | $4.99B(-44.5%) | $1.15B(-6.3%) | $4.74B(-24.0%) |
| Sep 2022 | - | $1.22B(+10.3%) | $6.23B(-9.1%) |
| Jun 2022 | - | $1.11B(-11.8%) | $6.86B(-24.6%) |
| Mar 2022 | - | $1.26B(-52.3%) | $9.09B(+1.6%) |
| Dec 2021 | $8.99B(+151.5%) | $2.64B(+42.9%) | $8.95B(+19.7%) |
| Sep 2021 | - | $1.85B(-44.8%) | $7.47B(+11.9%) |
| Jun 2021 | - | $3.35B(+200.8%) | $6.68B(+67.5%) |
| Mar 2021 | - | $1.11B(-4.7%) | $3.99B(+11.5%) |
| Dec 2020 | $3.58B(+61.9%) | $1.17B(+10.8%) | $3.58B(+15.9%) |
| Sep 2020 | - | $1.05B(+60.4%) | $3.09B(+11.4%) |
| Jun 2020 | - | $656.40M(-6.2%) | $2.77B(+14.0%) |
| Mar 2020 | - | $700.10M(+3.6%) | $2.43B(+10.0%) |
| Dec 2019 | $2.21B(-12.8%) | $675.70M(-8.5%) | $2.21B(-1.9%) |
| Sep 2019 | - | $738.50M(+134.0%) | $2.25B(+5.2%) |
| Jun 2019 | - | $315.60M(-34.3%) | $2.14B(-12.5%) |
| Mar 2019 | - | $480.00M(-33.2%) | $2.45B(-3.4%) |
| Dec 2018 | $2.53B(+21.9%) | $718.10M(+14.5%) | $2.53B(+7.6%) |
| Sep 2018 | - | $626.90M(+0.8%) | $2.36B(+2.9%) |
| Jun 2018 | - | $622.20M(+9.7%) | $2.29B(+3.2%) |
| Mar 2018 | - | $567.20M(+5.3%) | $2.22B(+6.6%) |
| Dec 2017 | $2.08B(+56.3%) | $538.82M(-3.8%) | $2.08B(+10.2%) |
| Sep 2017 | - | $559.93M(+1.7%) | $1.89B(+11.7%) |
| Jun 2017 | - | $550.31M(+27.8%) | $1.69B(+18.1%) |
| Mar 2017 | - | $430.54M(+24.1%) | $1.43B(+7.6%) |
| Dec 2016 | $1.33B(+6.3%) | $346.96M(-4.4%) | $1.33B(+9.5%) |
| Sep 2016 | - | $362.80M(+24.4%) | $1.21B(-2.4%) |
| Jun 2016 | - | $291.63M(-11.4%) | $1.24B(-4.1%) |
| Mar 2016 | - | $329.31M(+42.5%) | $1.30B(+3.7%) |
| Dec 2015 | $1.25B(+51.9%) | $231.08M(-41.1%) | $1.25B(+1.2%) |
| Sep 2015 | - | $392.42M(+13.8%) | $1.24B(+19.8%) |
| Jun 2015 | - | $344.86M(+21.6%) | $1.03B(+12.7%) |
| Mar 2015 | - | $283.55M(+31.4%) | $915.91M(+11.2%) |
| Dec 2014 | $823.92M(+10.9%) | $215.80M(+14.5%) | $823.92M(+2.6%) |
| Sep 2014 | - | $188.46M(-17.4%) | $803.21M(-5.7%) |
| Jun 2014 | - | $228.09M(+19.1%) | $851.55M(+9.0%) |
| Mar 2014 | - | $191.56M(-1.8%) | $781.56M(+5.2%) |
| Dec 2013 | $743.05M(+62.3%) | $195.09M(-17.6%) | $743.05M(+7.1%) |
| Sep 2013 | - | $236.80M(+49.8%) | $693.63M(+5.2%) |
| Jun 2013 | - | $158.10M(+3.3%) | $659.19M(+12.0%) |
| Mar 2013 | - | $153.05M(+5.1%) | $588.56M(+28.6%) |
| Dec 2012 | $457.71M(-323.1%) | $145.67M(-28.0%) | $457.71M(+71.7%) |
| Sep 2012 | - | $202.36M(+131.3%) | $266.64M(+4481.5%) |
| Jun 2012 | - | $87.48M(+294.0%) | $5.82M(-104.1%) |
| Mar 2012 | - | $22.20M(-148.9%) | -$141.98M(-30.8%) |
| Dec 2011 | -$205.16M(+110.5%) | -$45.40M(-22.3%) | -$205.16M(+18.9%) |
| Sep 2011 | - | -$58.46M(-3.1%) | -$172.53M(+18.0%) |
| Jun 2011 | - | -$60.32M(+47.2%) | -$146.17M(+33.4%) |
| Mar 2011 | - | -$40.98M(+220.7%) | -$109.58M(+12.4%) |
| Dec 2010 | -$97.47M(+31.5%) | -$12.78M(-60.2%) | -$97.47M(-21.5%) |
| Sep 2010 | - | -$32.09M(+35.3%) | -$124.10M(+33.0%) |
| Jun 2010 | - | -$23.72M(-17.8%) | -$93.30M(+8.7%) |
| Mar 2010 | - | -$28.88M(-26.7%) | -$85.84M(+15.8%) |
| Dec 2009 | -$74.10M(-14.1%) | -$39.41M(+2952.5%) | -$74.10M(+12.8%) |
| Sep 2009 | - | -$1.29M(-92.1%) | -$65.71M(-22.1%) |
| Jun 2009 | - | -$16.27M(-5.1%) | -$84.35M(-3.8%) |
| Mar 2009 | - | -$17.14M(-44.7%) | -$87.71M(+1.4%) |
| Dec 2008 | -$86.25M(-24.6%) | -$31.02M(+55.6%) | -$86.48M(+29.1%) |
| Sep 2008 | - | -$19.93M(+1.6%) | -$67.00M(-21.9%) |
| Jun 2008 | - | -$19.62M(+23.3%) | -$85.73M(-11.4%) |
| Mar 2008 | - | -$15.91M(+37.9%) | -$96.72M(-15.5%) |
| Dec 2007 | -$114.45M | -$11.53M(-70.2%) | -$114.45M(-16.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2007 | - | -$38.67M(+26.3%) | -$136.41M(+8.3%) |
| Jun 2007 | - | -$30.60M(-9.0%) | -$126.00M(+5.3%) |
| Mar 2007 | - | -$33.65M(+0.5%) | -$119.64M(+11.1%) |
| Dec 2006 | -$107.66M(-186.5%) | -$33.49M(+18.5%) | -$107.66M(-174.2%) |
| Sep 2006 | - | -$28.26M(+16.5%) | $145.15M(+4.4%) |
| Jun 2006 | - | -$24.25M(+11.9%) | $139.02M(+6.0%) |
| Mar 2006 | - | -$21.66M(-109.9%) | $131.10M(+5.4%) |
| Dec 2005 | $124.42M(+2103.7%) | $219.31M(-737.8%) | $124.42M(-236.8%) |
| Sep 2005 | - | -$34.39M(+6.9%) | -$90.92M(+37.7%) |
| Jun 2005 | - | -$32.17M(+13.5%) | -$66.01M(+42.0%) |
| Mar 2005 | - | -$28.34M(-813.1%) | -$46.49M(-923.4%) |
| Dec 2004 | $5.65M(-105.6%) | $3.97M(-141.9%) | $5.65M(-136.5%) |
| Sep 2004 | - | -$9.48M(-25.0%) | -$15.47M(-51.2%) |
| Jun 2004 | - | -$12.64M(-153.1%) | -$31.69M(-33.4%) |
| Mar 2004 | - | $23.79M(-238.8%) | -$47.60M(-52.3%) |
| Dec 2003 | -$99.99M(-18.0%) | -$17.14M(-33.3%) | -$99.78M(-14.9%) |
| Sep 2003 | - | -$25.70M(-10.0%) | -$117.27M(-5.2%) |
| Jun 2003 | - | -$28.56M(+0.6%) | -$123.74M(-1.1%) |
| Mar 2003 | - | -$28.38M(-18.1%) | -$125.14M(+2.6%) |
| Dec 2002 | -$121.95M(+42.3%) | -$34.63M(+7.6%) | -$121.95M(+4.3%) |
| Sep 2002 | - | -$32.18M(+7.4%) | -$116.91M(+8.2%) |
| Jun 2002 | - | -$29.95M(+18.9%) | -$108.03M(+12.3%) |
| Mar 2002 | - | -$25.19M(-14.9%) | -$96.17M(+12.2%) |
| Dec 2001 | -$85.68M(+239.0%) | -$29.59M(+27.0%) | -$85.68M(+30.1%) |
| Sep 2001 | - | -$23.29M(+28.8%) | -$65.88M(+13.4%) |
| Jun 2001 | - | -$18.09M(+22.9%) | -$58.07M(+32.4%) |
| Mar 2001 | - | -$14.71M(+50.3%) | -$43.87M(+16.6%) |
| Dec 2000 | -$25.28M(+6.2%) | -$9.79M(-36.8%) | -$37.64M(+31.8%) |
| Sep 2000 | - | -$15.49M(+298.9%) | -$28.55M(+57.2%) |
| Jun 2000 | - | -$3.88M(-54.2%) | -$18.16M(-19.9%) |
| Mar 2000 | - | -$8.48M(+1111.4%) | -$22.68M(-7.8%) |
| Dec 1999 | -$23.80M(+90.4%) | -$700.00K(-86.3%) | -$24.60M(-17.7%) |
| Sep 1999 | - | -$5.10M(-39.3%) | -$29.90M(+9.9%) |
| Jun 1999 | - | -$8.40M(-19.2%) | -$27.20M(+50.3%) |
| Mar 1999 | - | -$10.40M(+73.3%) | -$18.10M(+43.7%) |
| Dec 1998 | -$12.50M(-8.8%) | -$6.00M(+150.0%) | -$12.60M(+8.6%) |
| Sep 1998 | - | -$2.40M(-442.9%) | -$11.60M(+12.6%) |
| Jun 1998 | - | $700.00K(-114.3%) | -$10.30M(-29.9%) |
| Mar 1998 | - | -$4.90M(-2.0%) | -$14.70M(+5.8%) |
| Dec 1997 | -$13.70M(-20.8%) | -$5.00M(+354.5%) | -$13.90M(+3.7%) |
| Sep 1997 | - | -$1.10M(-70.3%) | -$13.40M(-19.8%) |
| Jun 1997 | - | -$3.70M(-9.8%) | -$16.70M(0.0%) |
| Mar 1997 | - | -$4.10M(-8.9%) | -$16.70M(-3.5%) |
| Dec 1996 | -$17.30M(+127.6%) | -$4.50M(+2.3%) | -$17.30M(+11.6%) |
| Sep 1996 | - | -$4.40M(+18.9%) | -$15.50M(+14.8%) |
| Jun 1996 | - | -$3.70M(-21.3%) | -$13.50M(+21.6%) |
| Mar 1996 | - | -$4.70M(+74.1%) | -$11.10M(+30.6%) |
| Dec 1995 | -$7.60M(-74.0%) | -$2.70M(+12.5%) | -$8.50M(-22.0%) |
| Sep 1995 | - | -$2.40M(+84.6%) | -$10.90M(-10.7%) |
| Jun 1995 | - | -$1.30M(-38.1%) | -$12.20M(-41.6%) |
| Mar 1995 | - | -$2.10M(-58.8%) | -$20.90M(-28.4%) |
| Dec 1994 | -$29.20M(-24.7%) | -$5.10M(+37.8%) | -$29.20M(-17.3%) |
| Sep 1994 | - | -$3.70M(-63.0%) | -$35.30M(-13.7%) |
| Jun 1994 | - | -$10.00M(-3.8%) | -$40.90M(+0.5%) |
| Mar 1994 | - | -$10.40M(-7.1%) | -$40.70M(+3.0%) |
| Dec 1993 | -$38.80M(+112.0%) | -$11.20M(+20.4%) | -$39.50M(+14.8%) |
| Sep 1993 | - | -$9.30M(-5.1%) | -$34.40M(+12.1%) |
| Jun 1993 | - | -$9.80M(+6.5%) | -$30.70M(+25.8%) |
| Mar 1993 | - | -$9.20M(+50.8%) | -$24.40M(+32.6%) |
| Dec 1992 | -$18.30M(+90.6%) | -$6.10M(+8.9%) | -$18.40M(+15.0%) |
| Sep 1992 | - | -$5.60M(+60.0%) | -$16.00M(+24.0%) |
| Jun 1992 | - | -$3.50M(+9.4%) | -$12.90M(+13.2%) |
| Mar 1992 | - | -$3.20M(-13.5%) | -$11.40M(+83.9%) |
| Dec 1991 | -$9.60M(+190.9%) | -$3.70M(+48.0%) | -$6.20M(-34.7%) |
| Sep 1991 | - | -$2.50M(+25.0%) | -$9.50M(+66.7%) |
| Jun 1991 | - | -$2.00M(-200.0%) | -$5.70M(+128.0%) |
| Mar 1991 | - | $2.00M(-128.6%) | -$2.50M(-24.2%) |
| Dec 1990 | -$3.30M | -$7.00M(-638.5%) | -$3.30M(-189.2%) |
| Sep 1990 | - | $1.30M(+8.3%) | $3.70M(+54.2%) |
| Jun 1990 | - | $1.20M(0.0%) | $2.40M(+100.0%) |
| Mar 1990 | - | $1.20M | $1.20M |
FAQ
- What is Regeneron Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual operating profit year-on-year change?
- What is Regeneron Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly operating profit year-on-year change?
- What is Regeneron Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals TTM operating profit year-on-year change?
What is Regeneron Pharmaceuticals annual operating income?
The current annual operating profit of REGN is $4.09B
What is the all time high annual operating profit for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual operating income is $8.99B
What is Regeneron Pharmaceuticals annual operating profit year-on-year change?
Over the past year, REGN annual operating income has changed by -$141.50M (-3.34%)
What is Regeneron Pharmaceuticals quarterly operating income?
The current quarterly operating profit of REGN is $591.70M
What is the all time high quarterly operating profit for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly operating income is $3.35B
What is Regeneron Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, REGN quarterly operating income has changed by -$159.70M (-21.25%)
What is Regeneron Pharmaceuticals TTM operating income?
The current TTM operating profit of REGN is $3.83B
What is the all time high TTM operating profit for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high TTM operating income is $9.09B
What is Regeneron Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, REGN TTM operating income has changed by -$20.80M (-0.54%)